Armata Pharmaceuticals, Inc. (ARMP) Reports Q3 Loss, Tops Revenue Estimates

Armata Pharmaceuticals, Inc. (ARMP) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to loss of $0.31 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 46.43%. A quarter ago, it was expected that this company would post a loss of $0.52 per share when it actually produced a loss of $0.65, delivering a surprise of -25%.Over the last four quarters, the company h ...